Weight Loss CAS 96829-58-2 Orlistat Powder for Treat Obesity

• Application: Home
• Disposable: Non-Disposable
• Gender: Unisex
• Side Effect: No
• Usage: For Oral Administration
• Pharmaceutical Technology: Chemical Synthesis
• Model NO.: HNB-0056
• Efficacy: Weight Loss & Slimming
• Transport Package: Aluminium Foil Bag, Cardboard Drum
• Trademark: HNB-Biotech
• Origin: Shaanxi, China
• Production Capacity: 5000kg/Month

Product Description

Weight Loss CAS 96829-58-2 Orlistat powder for Treat Obesity

Product name	Orlistat
Cas No.	96829-58-2
Molecular Formula	C29H53NO5
Appearance	White crystalline powder

Orlistat belongs to the lipase inhibitor class of weight loss drugs. It is a hydrating derivative of lipstatin, which can reduce the absorption of fat in food, thus leading to weight loss.This product has a strong and selective inhibitory effect on gastric lipase and pancreatic lipase, and has no effect on other digestive enzymes (amylase, trypsin, chymotrypsin) and phospholipase, and does not affect the absorption of carbohydrates, proteins and phospholipids.The drug was not absorbed by the gastrointestinal tract and the inhibition of lipase was reversible.
Orlistat mainly inactivates the enzyme in the gastrointestinal tract by covalently binding with the serine residues in the active sites of gastric lipase and pancreatic lipase, inhibiting the hydrolysis of triacylglycerol, reducing the intake of mono glycerol and free fatty acids, thus controlling body weight.The pharmacological activity of orlistat is dose-dependent, and the therapeutic dose of orlistat (120 mg/ d, tid, taken with meals) in combination with a slightly low-calorie balanced diet reduces dietary fat absorption by 30%.